$VICR

Vicor (NASDAQ:VICR) Shares Gap Up – Here’s Why

Vicor (NASDAQ:VICR) shares opened higher Tuesday after closing at $267.99 and opening at $296.45; last traded at $300.85 on volume of 242,290. The move followed recent analyst target changes, including Needham raising its price objective to $260 and Roth Mkm reaffirming $245. On April 21, Vicor reported Q1 EPS of $0.44 vs $0.40 expected and revenue of $112.97M vs $109.05M.

Original reporting
Published May 26, 2026, 6:30 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai May 26, 2026, 7:19 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Vicor (NASDAQ:VICR) Shares Gap Up – Here’s Why — source image
Decision brief

The 30-second read

$VICRBullishMed
01

Why it matters

Earnings beat and favorable analyst actions provide a clear fundamental catalyst for repricing; the disclosed CEO share sale is a secondary sentiment factor that may cap upside or raise near-term skepticism.

02

Market read

Traders are likely reacting to the combination of an EPS/revenue beat and updated Street views, with valuation and insider selling as key watch items.

03

What to watch

Insider selling (CEO Form 4 sale) and the large spread between recent moving averages (50-day ~$219.98 vs 200-day ~$163.18) could increase sensitivity to any guidance/forward-demand concerns not covered here.

Relevance 9/10Timing: Gap-up occurred prior to Tuesday trading; the catalyst is tied to recent earnings/analyst updates rather than same-day new fundamentals.

Background

The piece summarizes Vicor’s pre-market gap, recent analyst rating/target changes, and the company’s latest reported quarterly results plus disclosed insider activity.

Company-level read

Ticker impact

$VICRBullishMedium confidence
Context

Vicor gapped up after reporting Q1 results that beat EPS and revenue expectations on April 21, driving near-term repricing.

Expected impact

Bias toward continued strength near the open/early session, with volatility risk if the market focuses on insider selling or valuation.

Evidence & confidence

The article cites an EPS beat ($0.44 vs $0.40) and revenue beat ($112.97M vs $109.05M), alongside multiple analyst rating/target updates; however, it also notes CEO insider sales and a high P/E (106.02).

Market effects

Strength in a modular power components name can support sentiment for high-efficiency power electronics suppliers, though the article is company-specific.

Limited; the news is US-listed and earnings-driven with no explicit regional demand shock described.

Limited; no explicit international contract, regulatory, or supply-chain disruption is mentioned.

Counterpoint

The gap-up may fade if traders treat the move as an earnings-reaction already priced in, especially given the stock’s high P/E (106.02).

Key entities

  • VICR

    Vicor Corporation; gap-up move tied to recent earnings beat and analyst target/rating updates, with additional context from insider selling.

Related articles

$VICRMedAI 8/10

Vicor (VICR) Q2 2026 Earnings Call Transcript

Vicor’s Q2 2026 earnings call reported product and royalty revenue of $143.4M, up 26.9% sequentially and 1.6% year over year. Advanced products revenue rose to $94.2M. Net income was $49.8M, GAAP diluted EPS $1.40, and cash was $453.6M. The company guided for nearly 10% Q3 revenue growth and over $600M 2026 revenue, citing capacity increases and licensing assumptions.

$VICRMed

Vicor Corp (VICR) Q2 2026 Earnings Call Highlights: Strong Revenue Growth

Vicor Corp said a new license agreement will bring $5 million quarterly payments in year one and $10 million in year two, with $15 million contributing to Q2 revenue and additional revenue recognition expected in Q3 and subsequent quarters. Management also discussed fab capacity expansion to support a $2.5 billion revenue goal and said backlog growth stems mainly from existing customer demand.

$VICRMed

VICOR CORP (VICR): Results of Operations and Financial Condition

VICOR CORP (VICR) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 d115827dex991.htm EX-99.1 EX-99.1 Exhibit 99.1 NEWS RELEASE FINANCIAL NEWS BRIEF July 21, 2026 For Immediate Release Vicor Corporation Reports Results for the Second Quarter Ended June 30, 2026 Andover, Mass., July 21, 2026 (GLOBE NEWSWIRE) — Vicor Corporation (NASDAQ:

$VICRMedAI 8/10

Vicor (NASDAQ:VICR) Reaches New 12

Vicor (NASDAQ:VICR) reached a new 52-week high on Wednesday, trading up to $334.62 and last at $332.95 versus a prior close of $267.99, with 1,586,277 shares traded. The stock also followed its April 21 quarterly results: EPS $0.44 vs $0.40 expected; revenue $112.97M vs $109.05M. Analysts cited mixed ratings and targets.

$AEHRHighAI 9/10

Here's Why Aehr Test Systems Popped Higher Today

Aehr Test Systems shares rose about 16% on the day, after Vicor unexpectedly raised its second-quarter revenue guidance, according to Vicor. Vicor cited higher product revenues and royalties from an additional licensee. Aehr, which sells wafer-level burn-in test equipment for power semiconductors and AI processors, reported a $41M hyperscaler order, lifting orders to over $92M in fiscal 2026 H2.